FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

385035002: Soluble tablet (qualifier value)


    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    1479297014 Soluble tablet en Synonym Active Entire term case insensitive SNOMED CT core module
    2660263019 Soluble tablet (qualifier value) en Fully specified name Active Entire term case insensitive SNOMED CT core module


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Soluble tablet Is a Tablet false Inferred relationship Existential restriction modifier
    Soluble tablet Is a Conventional release oral tablet false Inferred relationship Existential restriction modifier

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Prednisolone 5mg soluble tablets (Accord Healthcare Ltd) 30 tablet 3 x 10 tablets Has dispensed dose form False Soluble tablet Inferred relationship Existential restriction modifier
    Prednisolone 5mg soluble tablets (Phoenix Labs Ltd) Has manufactured dose form False Soluble tablet Inferred relationship Existential restriction modifier
    Prednisolone 5mg soluble tablets (Phoenix Labs Ltd) Has dispensed dose form False Soluble tablet Inferred relationship Existential restriction modifier
    Prednisolone 5mg soluble tablets (Phoenix Labs Ltd) 30 tablet 3 x 10 tablets Has dispensed dose form False Soluble tablet Inferred relationship Existential restriction modifier
    Memantine 10mg soluble tablets sugar free Has dispensed dose form False Soluble tablet Inferred relationship Existential restriction modifier
    Memantine 15mg soluble tablets sugar free Has dispensed dose form False Soluble tablet Inferred relationship Existential restriction modifier
    Memantine 20mg soluble tablets sugar free Has dispensed dose form False Soluble tablet Inferred relationship Existential restriction modifier
    Memantine 5mg soluble tablets sugar free Has dispensed dose form False Soluble tablet Inferred relationship Existential restriction modifier
    Alzhok 10mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Has dispensed dose form False Soluble tablet Inferred relationship Existential restriction modifier
    Alzhok 20mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Has dispensed dose form False Soluble tablet Inferred relationship Existential restriction modifier
    Alzhok 5mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Has dispensed dose form False Soluble tablet Inferred relationship Existential restriction modifier
    Alzhok 15mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Has dispensed dose form False Soluble tablet Inferred relationship Existential restriction modifier
    Memantine 15mg soluble tablets sugar free 7 tablet Has dispensed dose form False Soluble tablet Inferred relationship Existential restriction modifier
    Memantine 5mg soluble tablets sugar free 7 tablet Has dispensed dose form False Soluble tablet Inferred relationship Existential restriction modifier
    Memantine 20mg soluble tablets sugar free 28 tablet Has dispensed dose form False Soluble tablet Inferred relationship Existential restriction modifier
    Memantine 10mg soluble tablets sugar free 28 tablet Has dispensed dose form False Soluble tablet Inferred relationship Existential restriction modifier
    Alzhok 10mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) 28 tablet 4 x 7 tablets Has dispensed dose form False Soluble tablet Inferred relationship Existential restriction modifier
    Alzhok 20mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) 28 tablet 4 x 7 tablets Has dispensed dose form False Soluble tablet Inferred relationship Existential restriction modifier
    Alzhok 5mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) 7 tablet Has dispensed dose form False Soluble tablet Inferred relationship Existential restriction modifier
    Alzhok 15mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) 7 tablet Has dispensed dose form False Soluble tablet Inferred relationship Existential restriction modifier
    Memantine 20mg soluble tablets sugar free 7 tablet Has dispensed dose form False Soluble tablet Inferred relationship Existential restriction modifier
    Memantine 10mg soluble tablets sugar free 7 tablet Has dispensed dose form False Soluble tablet Inferred relationship Existential restriction modifier
    Alzhok 10mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) 7 tablet Has dispensed dose form False Soluble tablet Inferred relationship Existential restriction modifier
    Alzhok 20mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) 7 tablet Has dispensed dose form False Soluble tablet Inferred relationship Existential restriction modifier
    Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Has manufactured dose form False Soluble tablet Inferred relationship Existential restriction modifier
    Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Has dispensed dose form False Soluble tablet Inferred relationship Existential restriction modifier
    Glensoludex 4mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Has manufactured dose form False Soluble tablet Inferred relationship Existential restriction modifier
    Glensoludex 4mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Has dispensed dose form False Soluble tablet Inferred relationship Existential restriction modifier
    Glensoludex 8mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Has manufactured dose form False Soluble tablet Inferred relationship Existential restriction modifier
    Glensoludex 8mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Has dispensed dose form False Soluble tablet Inferred relationship Existential restriction modifier
    Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) 50 tablet Has dispensed dose form False Soluble tablet Inferred relationship Existential restriction modifier
    Glensoludex 4mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) 50 tablet Has dispensed dose form False Soluble tablet Inferred relationship Existential restriction modifier
    Glensoludex 8mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) 50 tablet Has dispensed dose form False Soluble tablet Inferred relationship Existential restriction modifier
    Memantine 10mg soluble tablets sugar free Has manufactured dose form False Soluble tablet Inferred relationship Existential restriction modifier
    Memantine 15mg soluble tablets sugar free Has manufactured dose form False Soluble tablet Inferred relationship Existential restriction modifier
    Memantine 20mg soluble tablets sugar free Has manufactured dose form False Soluble tablet Inferred relationship Existential restriction modifier
    Memantine 5mg soluble tablets sugar free Has manufactured dose form False Soluble tablet Inferred relationship Existential restriction modifier
    Paracetamol 120mg pediatric soluble tablet Has manufactured dose form False Soluble tablet Inferred relationship Existential restriction modifier
    Alzhok 10mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Has manufactured dose form False Soluble tablet Inferred relationship Existential restriction modifier
    Alzhok 5mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Has manufactured dose form False Soluble tablet Inferred relationship Existential restriction modifier
    Alzhok 15mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Has manufactured dose form False Soluble tablet Inferred relationship Existential restriction modifier
    Alzhok 20mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Has manufactured dose form False Soluble tablet Inferred relationship Existential restriction modifier

    Start Previous Page 3 of 3


    This concept is not in any reference sets

    Back to Start